Stock Earnings

Question 1

HLS Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、HLS Therapeutics Incの総資産は$159で、純lossは$-19です。

Question 2

HLTRFの主要な財務比率は何ですか？

Accepted Answer

HLS Therapeutics Incの流動比率は1.8、純利益率は-33.92、1株当たり売上高は$1.75です。

Question 3

HLS Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

HLS Therapeutics Inc largest revenue segment is Pharmaceutical, at a revenue of 77,565,856 in the most earnings release.For geography, Canada is the primary market for HLS Therapeutics Inc, at a revenue of 58,423,383.

Question 4

HLS Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、HLS Therapeutics Incの純lossは$-19です。

Question 5

HLS Therapeutics Incに負債はありますか？

Accepted Answer

yes、HLS Therapeutics Incの負債は88です。

Question 6

HLS Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

HLS Therapeutics Incの総発行済株式数は31.79株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	56	56	63	61	60	56
Revenue Growth (YoY)	-3%	-11%	3%	2%	7%	4%
Cost of Revenue	9	8	7	5	4	3
Gross Profit	46	47	55	56	56	52
Selling, General & Admin	29	32	33	35	32	31
Research & Development	--	--	--	--	--	--
Operating Expenses	53	56	67	70	62	64
Other Non Operating Income (Expenses)	--	--	--	--	0	0
Pretax Income	-14	-15	-27	-23	-11	-16
Income Tax Expense	0	4	0	0	1	-1
Net Income	-15	-19	-27	-23	-13	-15
Net Income Growth	-38%	-30%	17%	77%	-13%	-21%
Shares Outstanding (Diluted)	31.64	31.83	32.26	32.4	32.2	31.7
Shares Change (YoY)	-1%	-1%	0%	1%	2%	8%
EPS (Diluted)	-0.47	-0.61	-0.85	-0.73	-0.41	-0.48
EPS Growth	-37%	-28%	17%	78%	-15%	-28%
Free Cash Flow	11	7	15	16	15	-23
Free Cash Flow Per Share	0.34	0.21	0.46	0.49	0.46	-0.72
Gross Margin	82.14%	83.92%	87.3%	91.8%	93.33%	92.85%
Operating Margin	-10.71%	-16.07%	-17.46%	-21.31%	-10%	-21.42%
Profit Margin	-26.78%	-33.92%	-42.85%	-37.7%	-21.66%	-26.78%
Free Cash Flow Margin	19.64%	12.5%	23.8%	26.22%	25%	-41.07%
EBITDA	15	13	20	21	24	21
EBITDA Margin	26.78%	23.21%	31.74%	34.42%	40%	37.5%
D&A For EBITDA	21	22	31	34	30	33
EBIT	-6	-9	-11	-13	-6	-12
EBIT Margin	-10.71%	-16.07%	-17.46%	-21.31%	-10%	-21.42%
Effective Tax Rate	0%	-26.66%	0%	0%	-9.09%	6.25%

HLS Therapeutics Inc (HLTRF) Price

HLTRF Stock Price Chart

HLTRF Income

Follow-Up Questions